Taking together these considerations, new chimeric compounds, derived from the connection of DCA and Nutlin through suitable biodegradable linkers, could simultaneously inhibit mitochondrial kinase PDK and prevent degradation of p53, to impede tumour development while minimising harm to normal cells. This evidence concerns the gene TP53 and neoplasm.